RZLT | Rezolute, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	4.15 - 4.45
52 Week Range	0.8800 - 6.19
Beta	0.18
Implied Volatility	131.59%
IV Rank	35.25%
Day's Volume	353,420
Average Volume	386,255
Shares Outstanding	57,943,100
Market Cap	254,370,209
Sector	Healthcare
Industry	Biotechnology
IPO Date	2013-01-14

Valuation
Profitability
Growth
Health
P/E Ratio	-3.46
Forward P/E Ratio	N/A
EPS	-1.27
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	59
Country	USA
Website	RZLT

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

RZLT's peers: AADI, ACXP, ADAG, ADVM, ANTX, ANIX, APRE, ATXS, AURA, AUTL, AVTE, BCAB, BCDA, NTRB, BNOX, CADL, PTIX, CCCC, CDXC, CELC, CING, CSBR, CYCC, DBVT, FBIOP, FBRX, FHTX, GHRS, GNFT, GNTA, HCWB, ICCC, IKNA, IMNM, INDP, IVA, JANX, LVTX, MNOV, MNPR, MOLN, NAUT, NLSP, NNVC, OPT, PHAR, PHVS, PRLD, PRTC, FRLN, ELDN, CLNN, RPHM, LRMR, ACRV, SLGL, SVRA, TPST, TRVI, VINC, XOMA, LSTA, NAMS, MLEC

*Chart delayed

Analyzing fundamentals for RZLT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see RZLT Fundamentals page.

Watching at RZLT technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on RZLT Technicals page.